AI assistant
Sending…
Structure Therapeutics Inc. — Director's Dealing 2025
Sep 23, 2025
31940_dirs_2025-09-22_13918ddb-a5af-4d3f-a663-208bb21ec123.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2025-09-18
Reporting Person: Hall Ashley (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-18 | Ordinary Shares | F | 6021 | $7.7433 | Disposed | 112317 | Direct |
Footnotes
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
More from Structure Therapeutics Inc.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 23
Regulatory Filings
2026
Apr 15
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 20